Sandy Canally of The Compliance Team tells us about how CMS has deemed a new infusion benefit and explains how this can be an opportunity for HME providers and DME pharmacies.
Effective Jan. 1 of this year, Medicare began covering home infusion therapy-associated services and devices, which has created new opportunities for HME providers and DME pharmacies.
Sandy Canally, RN, founder and CEO of accrediting organization The Compliance Team discusses the benefit and explains how this can be an solid opportunity for enterprising providers and pharmacies looking to expand their revenues, as well as how they can tap into it.
Watch below or on YouTube.
About the Author
David Kopf is the Publisher and Executive Editor of HME Business and DME Pharmacy magazines. Follow him on LinkedIn at linkedin.com/in/dkopf/ and on Twitter at @postacutenews.
Contact the Editor.